INDIVIDUALIZED TREATMENT OF EYE DISEASE
- 专利权人:
- Mayo Foundation for Medical Education and Research
- 发明人:
- Raymond Iezzi
- 申请号：
- US15308317
- 公开号：
- US20170056469A1
- 申请日:
- 2015.05.01
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要：
- Methods are described for individualizing a patient's treatment for an eye disease that is mediated by vascular-derived endothelial growth factor.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Application of the dopaminergic receptors type 2 agonists in treatment of eye chronic diseases caused by the increased level of endothelium derivative cell growth factor
- DOSING REGIMES FOR THE TREATMENT OF OCULAR VASCULAR DISEASE
- USE OF NERVE GROWTH FACTOR IN EYE-DROPS FOR THERAPY OF PATHOLOGIES OF THE CENTRAL NERVOUS SYSTEM, SUCH AS ALZHEIMERS AND PARKINSONS DISEASE
- MODIFIED FIBROBLAST GROWTH FACTORS-1 FOR TREATMENT OF EYE DISORDERS
